Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


ERIS LIFESCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.2%
Tue, 19 Nov 9:22

ERIS LIFESCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.2%Image source: phive2015/www.istockphoto.com

ERIS LIFESCIENCES share price has zoomed 4% and is presently trading at Rs 1,345.0.

Meanwhile, the BSE HEALTHCARE index is at 42,193.7 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Biocon (up 2.9%) and GSK Pharma (up 2.0%).

GLAND PHARMA (down 1.8%) and DR. LAL PATHLABS (down 1.6%) are among the top losers today.

Over the last one year, ERIS LIFESCIENCES has moved up from Rs 897.4 to Rs 1,345.0, registering a gain of Rs 447.7 (up 49.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,951.5 to 42,193.7, registering a gain of 45.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 177.8%), SUVEN PHARMACEUTICALS (up 124.6%) and Glenmark Pharma (up 100.5%).

Revealed: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 77,548.0 (up 0.3%).

The top gainers among the BSE Sensex today are Nestle (up 2.0%) and Tech Mahindra (up 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 23,590.1 (up 0.6%). NTPC and Trent are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,675.9 to 77,548.0, registering a gain of 11,872.1 points (up 18.1%).

ERIS LIFESCIENCES Financial Update...

ERIS LIFESCIENCES net profit fell 21.2% YoY to Rs 964 million for the quarter ended September 2024, compared to a profit of Rs 1,223 million a year ago. Net sales rose 46.7% to Rs 7,412 million during the period as against Rs 5,053 million in July-September 2023.

For the year ended March 2024, ERIS LIFESCIENCES reported 6.1% increase in net profit to Rs 3,971 million compared to net profit of Rs 3,742 million during FY23. Revenue of the company grew 19.2% to Rs 20,091 million during FY24.

The current Price to earnings ratio of ERIS LIFESCIENCES, based on rolling 12 month earnings, stands at 49.9.


Equitymaster requests your view! Post a comment on "ERIS LIFESCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.2%". Click here!